United Services Automobile Association Amgen Inc Transaction History

United Services Automobile Association

$3.92 Billion
Q2 2024

A detailed history of United Services Automobile Association transactions in Amgen Inc stock. As of the latest transaction made, United Services Automobile Association holds 15,345 shares of AMGN stock, worth $4.95 Million. This represents 0.12% of its overall portfolio holdings.

Number of Shares

15,345

Previous 15,995 4.06%

Holding current value

$4.95 Million

Previous $4.55 Million 5.43%

% of portfolio

0.12%

Previous 0.11%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 06, 2024	SELL	$262.75 - $319.31 $170,787 - $207,551	-650 Reduced 4.06%	15,345 $4.79 Million
Q1 2024 May 15, 2024	SELL	$268.87 - $324.56 $25.1 Million - $30.3 Million	-93,393 Reduced 85.38%	15,995 $4.55 Million
Q4 2023 Feb 12, 2024	BUY	$255.7 - $288.46 $450,543 - $508,266	1,762 Added 1.64%	109,388 $31.5 Million
Q3 2023 Nov 14, 2023	SELL	$218.65 - $271.46 $11.5 Million - $14.2 Million	-52,411 Reduced 32.75%	107,626 $28.9 Million
Q2 2023 Aug 14, 2023	BUY	$214.27 - $253.37 $16,498 - $19,509	77 Added 0.05%	160,037 $35.5 Million
Q1 2023 May 15, 2023	SELL	$225.79 - $275.2 $477,771 - $582,323	-2,116 Reduced 1.31%	159,960 $38.7 Million
Q4 2022 Feb 14, 2023	SELL	$229.03 - $291.01 $184,598 - $234,554	-806 Reduced 0.49%	162,076 $42.6 Million
Q3 2022 Nov 14, 2022	BUY	$224.46 - $253.15 $5,835 - $6,581	26 Added 0.02%	162,882 $36.7 Million
Q2 2022 Aug 16, 2022	BUY	$230.71 - $256.74 $4.76 Million - $5.29 Million	20,623 Added 14.5%	162,856 $39.6 Million
Q1 2022 May 13, 2022	SELL	$219.27 - $242.57 $8.36 Million - $9.25 Million	-38,114 Reduced 21.13%	142,233 $34.4 Million
Q4 2021 Feb 16, 2022	SELL	$198.88 - $227.6 $425,603 - $487,064	-2,140 Reduced 1.17%	180,347 $40.6 Million
Q3 2021 Nov 15, 2021	BUY	$212.27 - $248.7 $1.23 Million - $1.44 Million	5,771 Added 3.27%	182,487 $38.8 Million
Q2 2021 Aug 16, 2021	BUY	$233.58 - $259.14 $11.8 Million - $13.1 Million	50,626 Added 40.15%	176,716 $43.1 Million
Q1 2021 May 14, 2021	BUY	$221.91 - $258.6 $846,586 - $986,559	3,815 Added 3.12%	126,090 $31.4 Million
Q3 2020 Nov 10, 2020	BUY	$234.65 - $260.95 $1.73 Million - $1.93 Million	7,393 Added 6.44%	122,275 $31.1 Million
Q2 2020 Aug 14, 2020	SELL	$197.81 - $242.74 $5.67 Million - $6.96 Million	-28,682 Reduced 19.98%	114,882 $27.1 Million
Q1 2020 May 14, 2020	BUY	$182.24 - $241.7 $890,242 - $1.18 Million	4,885 Added 3.52%	143,564 $29.1 Million
Q4 2019 Jan 14, 2020	SELL	$189.21 - $243.2 $544,735 - $700,172	-2,879 Reduced 2.03%	138,679 $33.4 Million
Q3 2019 Nov 13, 2019	SELL	$174.11 - $208.62 $111 Million - $133 Million	-636,828 Reduced 81.81%	141,558 $27.4 Million
Q2 2019 Aug 16, 2019	BUY	$166.7 - $195.41 $16.8 Million - $19.6 Million	100,540 Added 14.83%	778,386 $143 Million
Q1 2019 May 13, 2019	BUY	$180.87 - $203.88 $10.6 Million - $12 Million	58,841 Added 9.51%	677,846 $129 Million
Q4 2018 Feb 13, 2019	BUY	$178.4 - $208.25 $2.1 Million - $2.45 Million	11,750 Added 1.93%	619,005 $121 Million
Q3 2018 Nov 13, 2018	SELL	$185.29 - $208.89 $4.79 Million - $5.4 Million	-25,853 Reduced 4.08%	607,255 $126 Million
Q2 2018 Sep 27, 2018	SELL	$166.05 - $186.51 $128 Million - $143 Million	-768,205 Reduced 54.82%	633,108 $117 Million
Q2 2018 Aug 10, 2018	BUY	$166.05 - $186.51 $109 Million - $123 Million	658,287 Added 88.6%	1,401,313 $147 Million
Q1 2018 May 14, 2018	SELL	$169.43 - $198.0 $31.4 Million - $36.7 Million	-185,554 Reduced 19.98%	743,026 $127 Million
Q4 2017 Feb 14, 2018	BUY	$168.79 - $188.59 $1.67 Million - $1.86 Million	9,874 Added 1.07%	928,580 $161 Million
Q3 2017 Nov 14, 2017	BUY	$167.29 - $191.0 $154 Million - $175 Million	918,706	918,706 $171 Million

Others Institutions Holding AMGN

# of Institutions

3,054

Shares Held

409M

Call Options Held

7.19M

Put Options Held

6.26M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $173B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of United Services Automobile Association, based on Form 13F filings with the SEC.

News

Stay updated on United Services Automobile Association with notifications on news.

Account

United Services Automobile Association Amgen Inc Transaction History